Clinical Trials Browser

Phase 2 × Advanced NSCLC × Immune Checkpoint Inhibitors × Clear all

NCT06751849 2024-12-30

Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment

Phase 2 Recruiting

Advanced NSCLC

NCT06751901 2024-12-30

Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment

Phase 2 Recruiting

Advanced NSCLC